Markets for CBD Products to Explode With New U.S. Hemp Legislation - Seite 3

Legislation Means A Huge New Playing Field That's Wide Open  

Already market watchers say industrial hemp may be yield bigger cash crop than marijuana, with its seeds, stalks, fibers and cannabinoids all used to make the innovative products. There are a number of commonplace goods we use every day that will be impacted by hemp legalization.

Cannabis and hemp supporting companies already moving on opportunities in the now wide-open marketplace can gain a significant edge from the new products. These include:

MariMed Inc. (OTCQB:MRMD) provides turnkey solutions to cannabis cultivators, producers, and dispensaries. The company specializes in solutions for securing and operating facilities, manufacturing and processing, dispensary, layouts, and designs, merchandising and sales. They have assisted clients with securing state-issued cannabis operating licenses in eight states with licensed partners and distributors in RI, DE, NV, MA, and MD and working with manufacturers in CA, CO, AZ, OR, WA and ME.

Canopy Growth Inc. (TSX:WEED) (NYSE:CGC) is the world's largest diversified cannabis company. Canopy boasts a wide offering of distinct brands and curated cannabis varieties in dried, oil and capsule forms.

Cronos Group (NASDAQ: CRON) (TSX:CRON) is hoping to grow through providing medical marijuana to international markets. The company has an exclusive cannabis supply agreement with Pohl-Boskamp, which distributes products to more than 12,000 pharmacies in Germany. Cronos is participating in a joint venture to supply medical marijuana to Australia, New Zealand, and Southeast Asia.

For a more information about The Yield Growth Corp. and legal marijuana businesses see the article at: http://usanewsgroup.com/2019/01/15/the-sleeping-giant-for-2019-just-woke-up-and-its-a-game-changer-for-investors-looking-to-diversify-into-a-multi-billion-dollar-sector/

Article Source: 

USA News Group

http://usanewsgroup.com

[e-mail]

Legal Disclaimer/Disclosure: This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of USA News Group only and are subject to change without notice. USA News Group assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.